When Douglas VanOort took the top job at cancer-testing firm NeoGenomics six years ago, he pledged to turn the company into the nation's premier oncology lab.
Continue reading your article with a Business Observer subscription.
What's included:
✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition